On Thursday, February 16, 2017, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, and Chief Financial Officer, Larry Betterley, will present at the LEERINK Partners 6th Annual Global Healthcare Conference at 3:00 p.m. Eastern Time.
You may access the live audio webcast and presentation materials in the events section of the company’s investor relations website, http://investors.csi360.com/Investors/Events.
About Cardiovascular Systems, Inc.
Cardiovascular Systems,
Inc., based in St. Paul, Minn., is a medical device company focused on
developing and commercializing innovative solutions for treating
vascular and coronary disease. The company’s Orbital Atherectomy Systems
treat calcified and fibrotic plaque in arterial vessels throughout the
leg and heart in a few minutes of treatment time, and address many of
the limitations associated with existing surgical, catheter and
pharmacological treatment alternatives. The U.S. FDA granted the first
510(k) clearance for the use of the Orbital Atherectomy System in
peripheral arteries in August 2007. In October 2013, the company
received FDA approval for the Coronary Orbital Atherectomy System. To
date, over 290,000 of CSI’s devices have been sold to leading
institutions across the United States. For more information, visit the
company’s website at www.csi360.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170209005042/en/
Contacts:
Jack Nielsen, 651-202-4919
j.nielsen@csi360.com
or
PadillaCRT
Matt
Sullivan, 612-455-1709
matt.sullivan@padillacrt.com